Superior efficacy of letrozole versus tamoxifen as first-line therapy for postmenopausal women with advanced breast cancer: results of a phase III study of the International Letrozole Breast Cancer Group (Q43607761)

From Wikidata
Jump to navigation Jump to search
scientific article
edit
Language Label Description Also known as
English
Superior efficacy of letrozole versus tamoxifen as first-line therapy for postmenopausal women with advanced breast cancer: results of a phase III study of the International Letrozole Breast Cancer Group
scientific article

    Statements

    Superior efficacy of letrozole versus tamoxifen as first-line therapy for postmenopausal women with advanced breast cancer: results of a phase III study of the International Letrozole Breast Cancer Group (English)
    H Mouridsen
    M Gershanovich
    R Pérez-Carrión
    A Monnier
    J Apffelstaedt
    H P Sleeboom
    F Jänicke
    D Becquart
    P P Bapsy
    E Salminen
    R Snyder
    M Lassus
    J A Verbeek
    B Staffler
    H A Chaudri-Ross
    M Dugan
    2596-2606

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit